Pathway-selective antagonism of proteinase activated receptor 2.
about
Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic ReviewDon't stress about CRF: assessing the translational failures of CRF1antagonists.PAR2 Modulators Derived from GB88.The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.Inhibitory effect of FSLLRY-NH2 on inflammatory responses induced by hydrogen peroxide in HepG2 cells.Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Homeostatic effects of coagulation protease-dependent signaling and protease activated receptors.Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor.Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction.Potent Small Agonists of Protease Activated Receptor 2.The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.Protease activated receptor 2 controls myelin development, resiliency and repair.Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients.
P2860
Q26752383-F8CB5835-5173-41F9-8FC1-D7EB601891C5Q30399543-677452F0-A676-4681-89D5-CD3222F2BF42Q34547663-A743F4BC-85B3-46D3-95F1-A47781DE9661Q36036250-649FB94E-DAF5-447E-BF2F-888BEF891A98Q36727411-DDEFA414-5005-4D0B-98C1-A42321D939E9Q37591794-0B4169BA-8654-4563-8E9C-AB051EFD616CQ38712691-9FB6F581-F919-4820-ACF4-F5864E833F93Q38758445-25E94846-0E8F-48E4-9E9B-B981BEE46E67Q39410950-CB7C5AA3-01D3-4D8F-A522-85D43162823FQ41341638-881E1B7F-56D6-4D20-97A8-9BA820C97590Q42650499-2B1EAE0B-8F4F-416C-955A-06A5790C3FDEQ42754556-54664ADE-0701-4530-9521-88C2C9E972F8Q43083912-6EA06258-84FA-4A66-AF47-3346D2604BB0Q47277683-518240B4-F6C2-4958-86ED-A92324A8A7C3Q47663969-DE7BD19F-F52C-422F-A98F-79713BD5D252Q48324759-897388C5-A62F-4A72-BDFC-5A98B2E8BBA7
P2860
Pathway-selective antagonism of proteinase activated receptor 2.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathway-selective antagonism of proteinase activated receptor 2.
@ast
Pathway-selective antagonism of proteinase activated receptor 2.
@en
Pathway-selective antagonism of proteinase activated receptor 2.
@nl
type
label
Pathway-selective antagonism of proteinase activated receptor 2.
@ast
Pathway-selective antagonism of proteinase activated receptor 2.
@en
Pathway-selective antagonism of proteinase activated receptor 2.
@nl
prefLabel
Pathway-selective antagonism of proteinase activated receptor 2.
@ast
Pathway-selective antagonism of proteinase activated receptor 2.
@en
Pathway-selective antagonism of proteinase activated receptor 2.
@nl
P2860
P50
P356
P1476
Pathway-selective antagonism of proteinase activated receptor 2.
@en
P2093
P2860
P304
P356
10.1111/BPH.12757
P407
P50
P577
2014-07-02T00:00:00Z